Cargando…

Asymptomatic COVID–19 cancer patients incidentally discovered during F18-FDG PET/CT monitoring

BACKGROUND: The aim of the study was to present the PET/CT imaging features in a small series of asymptomatic patients with known cancer pathologies, infected with the SARS-CoV-2 virus, which were incidentally discovered during their monitoring scan of F18-FDG PET/CT. METHODS: We included in our stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Piciu, Andra, Manole, Simona, Piciu, Doina, Dreve, Teodora, Roman, Andrei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880066/
https://www.ncbi.nlm.nih.gov/pubmed/33629050
http://dx.doi.org/10.15386/mpr-1776
_version_ 1783650639982624768
author Piciu, Andra
Manole, Simona
Piciu, Doina
Dreve, Teodora
Roman, Andrei
author_facet Piciu, Andra
Manole, Simona
Piciu, Doina
Dreve, Teodora
Roman, Andrei
author_sort Piciu, Andra
collection PubMed
description BACKGROUND: The aim of the study was to present the PET/CT imaging features in a small series of asymptomatic patients with known cancer pathologies, infected with the SARS-CoV-2 virus, which were incidentally discovered during their monitoring scan of F18-FDG PET/CT. METHODS: We included in our study a number of five cases (3 female and 2 male) out of 478 patients examined by F18-FDG PET/CT between March – April 2020, with confirmed diagnostic of cancer. Four patients had lung damages suggestive for the mentioned viral infection and 1 patient had multiple lung metastases from thyroid cancer. All patients were asymptomatic for acute respiratory disease at the time of examination, being subsequently confirmed for the viral infection by specific PCR analysis. RESULTS: The asymptomatic positive SARS-CoV-2 cancer patients discovered incidentally in PET/CT F18-FDG represent 0.83% and their imaging characteristics were suggestive for high FDG activity in the lung despite the lack of respiratory symptoms. CONCLUSION: The SARS CoV-2 viral infection in asymptomatic cancer patients is a very rare possibility, but represents a challenging scenario both for the differential diagnosis in cancer and also for the epidemiologic context.
format Online
Article
Text
id pubmed-7880066
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Iuliu Hatieganu University of Medicine and Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-78800662021-02-23 Asymptomatic COVID–19 cancer patients incidentally discovered during F18-FDG PET/CT monitoring Piciu, Andra Manole, Simona Piciu, Doina Dreve, Teodora Roman, Andrei Med Pharm Rep Original Research BACKGROUND: The aim of the study was to present the PET/CT imaging features in a small series of asymptomatic patients with known cancer pathologies, infected with the SARS-CoV-2 virus, which were incidentally discovered during their monitoring scan of F18-FDG PET/CT. METHODS: We included in our study a number of five cases (3 female and 2 male) out of 478 patients examined by F18-FDG PET/CT between March – April 2020, with confirmed diagnostic of cancer. Four patients had lung damages suggestive for the mentioned viral infection and 1 patient had multiple lung metastases from thyroid cancer. All patients were asymptomatic for acute respiratory disease at the time of examination, being subsequently confirmed for the viral infection by specific PCR analysis. RESULTS: The asymptomatic positive SARS-CoV-2 cancer patients discovered incidentally in PET/CT F18-FDG represent 0.83% and their imaging characteristics were suggestive for high FDG activity in the lung despite the lack of respiratory symptoms. CONCLUSION: The SARS CoV-2 viral infection in asymptomatic cancer patients is a very rare possibility, but represents a challenging scenario both for the differential diagnosis in cancer and also for the epidemiologic context. Iuliu Hatieganu University of Medicine and Pharmacy 2021-01 2021-01-29 /pmc/articles/PMC7880066/ /pubmed/33629050 http://dx.doi.org/10.15386/mpr-1776 Text en This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Research
Piciu, Andra
Manole, Simona
Piciu, Doina
Dreve, Teodora
Roman, Andrei
Asymptomatic COVID–19 cancer patients incidentally discovered during F18-FDG PET/CT monitoring
title Asymptomatic COVID–19 cancer patients incidentally discovered during F18-FDG PET/CT monitoring
title_full Asymptomatic COVID–19 cancer patients incidentally discovered during F18-FDG PET/CT monitoring
title_fullStr Asymptomatic COVID–19 cancer patients incidentally discovered during F18-FDG PET/CT monitoring
title_full_unstemmed Asymptomatic COVID–19 cancer patients incidentally discovered during F18-FDG PET/CT monitoring
title_short Asymptomatic COVID–19 cancer patients incidentally discovered during F18-FDG PET/CT monitoring
title_sort asymptomatic covid–19 cancer patients incidentally discovered during f18-fdg pet/ct monitoring
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880066/
https://www.ncbi.nlm.nih.gov/pubmed/33629050
http://dx.doi.org/10.15386/mpr-1776
work_keys_str_mv AT piciuandra asymptomaticcovid19cancerpatientsincidentallydiscoveredduringf18fdgpetctmonitoring
AT manolesimona asymptomaticcovid19cancerpatientsincidentallydiscoveredduringf18fdgpetctmonitoring
AT piciudoina asymptomaticcovid19cancerpatientsincidentallydiscoveredduringf18fdgpetctmonitoring
AT dreveteodora asymptomaticcovid19cancerpatientsincidentallydiscoveredduringf18fdgpetctmonitoring
AT romanandrei asymptomaticcovid19cancerpatientsincidentallydiscoveredduringf18fdgpetctmonitoring